Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Lexaria Corp. (Lexaria Bioscience Corp.) on October 27, 2009, covering events occurring on October 26 and October 28, 2009. The registrant is incorporated in Nevada and maintains its principal executive offices in Vancouver, British Columbia, Canada.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance and trading status update rather than financial performance.
Material Changes
- Trading Venue Expansion: Effective at the open of market on October 28, 2009, the Company's shares began trading on the Canadian Stock Exchange (CNSX) under the symbol "LXX".
- Currency Quotation: Shares on the CNSX will be quoted in Canadian currency.
- Continued US Trading: Lexaria shares will continue to trade on the OTCBB in US currency.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves solely as a Regulation FD disclosure regarding the new trading symbol and venue.
Investor Verification Checklist
- Verify the trading symbol "LXX" on the Canadian Stock Exchange (CNSX).
- Confirm the continued availability of shares on the OTCBB in US currency.
- Review the attached News Release (Exhibit 99.1) for any additional details on the listing process.